These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8650431)

  • 21. [Calcium antagonists--drug preparations with a wide spectrum of use].
    Eliseev OM
    Ter Arkh; 1990; 62(10):128-32. PubMed ID: 2084876
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcium channel blockers: summary and safety issues.
    Opie LH
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():893-5. PubMed ID: 9126679
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium channel blockers in myocardial and cerebral ischemia: a clinician's review from bench to bedside.
    Borger MA; Weisel RD
    Can J Cardiol; 1999 Mar; 15(3):333-40. PubMed ID: 10202197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALLHAT and calcium channel blockers. ALLHAT Research Group.
    Proschan M; Davis B; Cutler J; Ford C; Furberg C; Grimm R; Oparil S
    Am J Hypertens; 1997 Jan; 10(1):142-3. PubMed ID: 9008261
    [No Abstract]   [Full Text] [Related]  

  • 25. [Calcium antagonists and hypertension: in search of absolute certainty].
    Mayer G
    Wien Klin Wochenschr; 1998 Oct; 110(18):621-4. PubMed ID: 9816633
    [No Abstract]   [Full Text] [Related]  

  • 26. Drugs for cardiac arrhythmias.
    Treat Guidel Med Lett; 2007 Jun; 5(58):51-8. PubMed ID: 17505408
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
    Apostolakos MJ; Varon ME
    New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium antagonists, is there a real concern about safety?
    Duprez DA; De Buyzere ML; Clement DL
    Acta Clin Belg; 1998 Apr; 53(2):61-5. PubMed ID: 9639942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do calcium channel blockers increase heart attack risk?
    Johns Hopkins Med Lett Health After 50; 1998 Nov; 10(9):8. PubMed ID: 9803183
    [No Abstract]   [Full Text] [Related]  

  • 31. Do intensive blood pressure lowering and low-dose ASA help our hypertensive patients?
    Evans MF
    Can Fam Physician; 1998 Dec; 44():2655-7. PubMed ID: 9870118
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].
    Palma-Aguirre JA; Campos-Lara M; Chávez-Negrete A
    Gac Med Mex; 2002; 138(4):381-3. PubMed ID: 12200885
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of calcium channel blockers in the treatment of cardiovascular diseases.
    Herman ZS
    Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Calcium inhibitors (author's transl)].
    Witchitz S
    Ann Cardiol Angeiol (Paris); 1982; 31(1):19-24. PubMed ID: 7039473
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE; Hamlin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel blockers, risk of cancer, and the challenge of assessing medication safety.
    Pahor M
    Tenn Med; 1997 Sep; 90(9):367-9. PubMed ID: 9308392
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy of antihypertensive drugs in pregnancy].
    Tsaava F; Shonia R
    Georgian Med News; 2005 Sep; (126):23-6. PubMed ID: 16234587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blockers in perspective.
    Harv Heart Lett; 1998 Aug; 8(12):1-3. PubMed ID: 9713233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.